Acesso DL

Acesso DL is a dual-layer human amniotic membrane allograft used as a sterile barrier and wound covering for acute and chronic wounds, including full- and partial-thickness wounds, ulcers, and other soft-tissue defects. It is derived from multiple amnion layers, providing a natural, biocompatible scaffold that adheres to irregular wound beds and supports native tissue by offering angiogenic, anti-inflammatory, and immune-privileged properties that promote healing while protecting the wound from the surrounding environment.[1][3][4][8][9][11] The dehydrated membrane is packaged sterile, e-beam sterilized to a high sterility assurance level, shelf stable for years at ambient conditions, and is regulated in the United States as a human cell, tissue, and cellular and tissue-based product (HCT/P) under 21 CFR 1270/1271 rather than as an FDA-approved drug or device.[1][8][9][11]

Brand names

Acesso DL

Other names

Acesso DL membraneAcesso DL Dual Layer Membrane